Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

WALGREENS BOOTS ALLIANCE, INC.

(WBA)
  Report
Delayed Nasdaq  -  04:00 2022-10-04 pm EDT
33.39 USD   +2.96%
10/04Walgreens Joins Sustainable Medicines Partnership
BU
10/03Walgreens expanding robot network to bolster pharmacy operations
AQ
10/03Evercore ISI Lowers Walgreens Boots Alliance's Price Target to $32 From $41, Maintains In Line Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Walgreens prescriptions added to San Francisco's opioid epidemic - judge

08/10/2022 | 11:12am EDT

Aug 10 (Reuters) - Walgreens Boots Alliance contributed to the opioid epidemic in San Francisco through its sale of prescription drugs in the city, a federal judge concluded on Wednesday.

U.S. District Judge Charles Breyer in San Francisco said that Walgreens failed to properly investigate suspicious opioid orders for nearly 15 years. The amount the pharmacy chain must pay will be determined in a later trial.

Walgreens' pharmacists filled hundreds of thousands of suspicious opioid prescriptions from 2006 to 2020 with pharmacists not given time, staffing or resources to properly investigate red flags, Breyer wrote.

San Francisco in 2018 sued Walgreens, as well as several drug manufacturers and distributors, over the opioid epidemic in the city, saying they created a "public nuisance" by flooding the city with prescription opioids and failing to prevent the drugs from being diverted for illegal use.

A trial began in April, and all of the defendants except Walgreens reached settlements with the city before the court ruled.

Breyer said San Francisco had shown that Walgreens' lax oversight led to illegal drug use that substantially contributed to the opioid epidemic in the city.

Walgreens said that it was disappointed with the ruling and intends to appeal.

"We never manufactured or marketed opioids, nor did we distribute them to the 'pill mills' and internet pharmacies that fueled this crisis," Walgreens spokesman Fraser Engerman said.

The opioid epidemic has caused more than 500,000 opioid overdose deaths over two decades, according to the U.S. Centers for Disease Control and Prevention. More than 3,300 opioid lawsuits have been filed nationally against drug manufacturers, distributors and pharmacies, culminating with many of the other companies - though not the pharmacies - agreeing to proposed global settlements.

The opioid crisis has hit San Francisco hard, with opioid-related emergency room tripling from 886 in 2015 to 2,998 in 2020, according to the court ruling.

Paul Geller, an attorney who represented the city in the case, credited San Francisco City Attorney David Chiu for working to hold companies accountable for contributing to "the horrific epidemic in the Bay Area.”

Walgreens was found liable in 2021 for contributing to the opioid epidemic in a similar trial brought by two Ohio counties. Walgreens and its co-defendants, CVS Health Inc and Walmart, are awaiting a ruling from the Ohio court on the amount they must pay to address the opioid crisis in those counties.

(Reporting by Dietrich Knauth; Editing by Mark Porter, Deepa Babington, Alexia Garamfalvi and Mike Harrison)


© Reuters 2022
Stocks mentioned in the article
ChangeLast1st jan.
CVS HEALTH CORPORATION 2.82% 100.52 Delayed Quote.-5.23%
WALGREENS BOOTS ALLIANCE, INC. 2.96% 33.39 Delayed Quote.-35.99%
WALMART INC. 1.30% 134.25 Delayed Quote.-8.40%
All news about WALGREENS BOOTS ALLIANCE, INC.
10/04Walgreens Joins Sustainable Medicines Partnership
BU
10/03Walgreens expanding robot network to bolster pharmacy operations
AQ
10/03Evercore ISI Lowers Walgreens Boots Alliance's Price Target to $32 From $41, Maintains ..
MT
10/03Walgreens to Donate $1 Million to Aid Communities Impacted by Hurricanes Ian and Fiona
BU
10/03North American Morning Briefing: Stock Futures Mixed as ..
DJ
09/30S&P 500 Posts 2.9% Weekly Drop, Down 9.3% for September, Ends Q3 With 5.3% Quarterly Lo..
MT
09/29Rite Aid Posts Wider-Than-Expected Fiscal Second-Quarter Loss, Sees Ongoing Consumer Sp..
MT
09/29Walgreens Boots Alliance, CVS Shares Move Lower in Wake of Wider Q2 Loss for Rite Aid
MT
09/29EEOC Sues Walgreens for Alleged Disability Discrimination
DJ
09/29Walgreens Mobilizes in Advance of Hurricane Ian with Guidance for Florida's Communities..
AQ
More news
Analyst Recommendations on WALGREENS BOOTS ALLIANCE, INC.
More recommendations
Financials (USD)
Sales 2022 132 B - -
Net income 2022 5 141 M - -
Net Debt 2022 9 403 M - -
P/E ratio 2022 5,63x
Yield 2022 5,75%
Capitalization 28 858 M 28 858 M -
EV / Sales 2022 0,29x
EV / Sales 2023 0,27x
Nbr of Employees 258 500
Free-Float 60,9%
Chart WALGREENS BOOTS ALLIANCE, INC.
Duration : Period :
Walgreens Boots Alliance, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends WALGREENS BOOTS ALLIANCE, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 19
Last Close Price 33,39 $
Average target price 41,50 $
Spread / Average Target 24,3%
EPS Revisions
Managers and Directors
Rosalind Gates Brewer Chief Executive Officer & Director
James Kehoe Global Chief Financial Officer & Executive VP
Stefano Pessina Executive Chairman
Kevin M. Ban Chief Medical Officer
Hsiao Wang Chief Information Officer & Senior Vice President